Guidelines on the management of arterial hypertension and related comorbidities in Latin America
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Univ Hosp, Hypertens & Metab Unit, Fdn Favaloro, Belgrano 1782 P 4, RA-1093 Buenos Aires, DF, Argentina
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Research works printed but not linked: 75
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Mengue, 2016, Acesso e uso de medicamentos para hipertensão arterial no Brasil, Rev Saude Publica, 50, 1s
- Oliveira Araujo, 2014, Access to antihypertensive agents in Brazil: evaluation of the ‘Health Has No Price’ program, Clin Ther, 36, 1191, 10.1016/j.clinthera.2014.06.003 · doi:10.1016/j.clinthera.2014.06.003
- Hernández-Hernández, 2010, Hypertension in seven Latin American cities: the Cardiovascular Risk Factor MultipleEvaluation in Latin America (CARMELA) study, J Hypertens, 28, 24, 10.1097/HJH.0b013e328332c353 · DOI · Paper page
- Schargrodsky, 2008, CARMELA: assessment of cardiovascular risk in seven Latin American cities, Am J Med, 121, 58, 10.1016/j.amjmed.2007.08.038 · DOI · Paper page
- Teo, 2009, The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries, Am Heart J, 158, 1, 10.1016/j.ahj.2009.04.019 · DOI · Paper page
- Chow, 2013, Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries, JAMA, 310, 959, 10.1001/jama.2013.184182 · DOI · Paper page
- Lopez Jaramillo, 2013, Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome, J Hypertens, 31, 223, 10.1097/HJH.0b013e32835c5444 · DOI · Paper page
- Alegre Diaz, 2016, Diabetes and cause-specific mortality in Mexico City, N Engl J Med, 17, 1961, 10.1056/NEJMoa1605368 · DOI · Paper page
- Holwerda, 2016, Arterial baroreflex control of sympathetic nerve activity and heart rate in patients with type 2 diabetes, Am J Physiol Heart Circ Physiol, 311, H1170, 10.1152/ajpheart.00384.2016 · DOI
- Gupta, 2016, Predictors of sleep disorders among patients with type 2 diabetes mellitus, Diabetes Metab Syndr, 10, 213, 10.1016/j.dsx.2016.06.009 · DOI
- DePace, 2014, Cardiac autonomic testing and diagnosing heart disease. ‘A clinical perspective’, Heart Int, 9, 37
- Sempertegui, 2011, Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador, Public Health Nutr, 14, 758, 10.1017/S1368980010002636 · DOI
- Alvarez, 2010, Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America, Braz J Infect Dis, 14, 256, 10.1016/S1413-8670(10)70053-2 · DOI
- Bermudez, 2010, The Maracaibo city metabolic syndrome prevalence study: design and scope, Am J Ther, 17, 288, 10.1097/MJT.0b013e3181c121bc · DOI
- Escobedo, 2009, Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study, Cardiovasc Diabetol, 26, 8
- Caceres, 2008, Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity, BMC Pediatr, 8, 1, 10.1186/1471-2431-8-31 · DOI
- Royer, 2007, The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women, Climacteric, 10, 164, 10.1080/13697130701258895 · DOI
- Garcia, 2007, Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome, Int J Cardiol, 122, 176, 10.1016/j.ijcard.2006.11.058 · DOI
- Alberti, 2009, Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 · DOI · Paper page
- Spence, 1996, Cerebral consequences of hypertension, J Hypertens, 14, S139
- Porcello Marrone, 2013, Risk factors among stroke subtypes Brazil, J Stroke Cerebrovasc Dis, 22, 32, 10.1016/j.jstrokecerebrovasdis.2011.05.022 · DOI
- De Jesús Llibre, 2010, Prevalence of stroke and associated risk factors in older adults in Havana city and Matanzas province, Cuba, MEDICC Rev, 12, 20, 10.37757/MR2010.V12.N3.6 · DOI
- Lanas, 2014, Cardiovascular disease in Latin America: the growing epidemic, Progr Cardiovasc Dis, 57, 262, 10.1016/j.pcad.2014.07.007 · DOI
- Manolio, 1994, Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study, Stroke, 25, 318, 10.1161/01.STR.25.2.318 · DOI · Paper page
- Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9 · DOI · Paper page
- Lanas, 2007, Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study, Circulation, 115, 1067, 10.1161/CIRCULATIONAHA.106.633552 · DOI · Paper page
- Dokainish, 2016, Heart failure in Africa, Asia, the Middle East and South America: the INTER-CHF study, Int J Cardiol, 204, 133, 10.1016/j.ijcard.2015.11.183 · DOI · Paper page
- Rodriguez, 2010, Left ventricular mass and ventricular remodelling among Hispanic subgroups compared with non-Hispanic blacks and whites MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 55, 234, 10.1016/j.jacc.2009.08.046 · DOI · Paper page
- Bocchi, 2013, The reality of heart failure in Latin America, J Am Coll Cardiol, 62, 949, 10.1016/j.jacc.2013.06.013 · doi:10.1016/j.jacc.2013.06.013
- Sacco, 2001, Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study, Stroke, 32, 1725, 10.1161/01.STR.32.8.1725 · DOI · Paper page
- Cowley, 1996, The role of the kidney in hypertension, JAMA, 275, 1581, 10.1001/jama.1996.03530440061038 · DOI · Paper page
- Textor, 2005, Atherosclerotic renal artery stenosis: how big is the problem and what happens if nothing is done?, J Hypertens, 23, s5, 10.1097/01.hjh.0000192096.83302.02 · doi:10.1097/01.hjh.0000192096.83302.02
- Krumme, 1996, Diagnosis of renovascular disease by intra- and extrarenal Doppler scanning, Kidney Int, 50, 1288, 10.1038/ki.1996.440 · DOI · Paper page
- Safian, 2001, Renal-artery stenosis, N Engl J Med, 344, 431, 10.1056/NEJM200102083440607 · DOI · Paper page
- Plouin, 1998, Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. EssaiMulticentrique Medicaments vs Angioplastie (EMMA) Study Group, Hypertension, 31, 823, 10.1161/01.HYP.31.3.823 · DOI · Paper page
- Rosa-Diez, 2014, Renal replacement therapy in Latin American end-stage renal disease, Clin Kidney J, 7, 431, 10.1093/ckj/sfu039 · doi:10.1093/ckj/sfu039
- Murabito, 1997, Intermittent claudication: a risk profile from the Framingham Heart Study, Circulation, 96, 44, 10.1161/01.CIR.96.1.44 · DOI · Paper page
- Bertomeu, 2008, Prevalence and prognostic influence of peripheral arterial disease in patients 40 years old admitted into hospital following an acute coronary event, Eur J Vasc Endovasc Surg, 36, 189, 10.1016/j.ejvs.2008.02.004 · DOI
- Ingolfsson, 1994, A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968–1986: a strong relationship to smoking and serum cholesterol the Reykjavik Study, J Clin Epidemiol, 47, 1237, 10.1016/0895-4356(94)90128-7 · DOI
- Sanchez, 2009, Latin American guidelines on hypertension, J Hypertens, 27, 905, 10.1097/HJH.0b013e32832aa6d2 · DOI · Paper page
- Mancia, 2011, Diagnosis and management of patients with white-coat and masked hypertension, Nat Rev Cardiol, 8, 686, 10.1038/nrcardio.2011.115 · DOI
- Longo, 2005, Masked hypertension in adults, Blood Press Monit, 10, 307, 10.1097/00126097-200512000-00004 · DOI
- Ho, 2014, Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study, J Am Heart Assoc, 3, e000668, 10.1161/JAHA.113.000668 · DOI · Paper page
- Palatini, 2016, Management of the hypertensive patient with elevated heart rate: statement of the second consensus conference endorsed by the European Society of Hypertension, J Hypertens, 34, 813, 10.1097/HJH.0000000000000865 · DOI · Paper page
- Kang, 2015, Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension, J Hypertens, 33, 1580, 10.1097/HJH.0000000000000596 · DOI
- Grotto, 2008, Hypertension and socio-economic status, Curr Opin Cardiol, 23, 335, 10.1097/HCO.0b013e3283021c70 · DOI · Paper page
- Flescher, 2008, Social patterning of chronic disease risk factors in a Latin American city, J Urban Health, 85, 923, 10.1007/s11524-008-9319-2 · DOI
- Lopez-Jaramillo, 2016, Is it time to reappraise blood pressure thresholds and targets? Position Statement of the Latin American Society of Hypertension, Hypertension, 68, 257, 10.1161/HYPERTENSIONAHA.116.07738 · DOI
- James, 2014, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA, 311, 507, 10.1001/jama.2013.284427 · DOI · Paper page
- Weber, 2014, Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension, J Hypertens, 32, 3, 10.1097/HJH.0000000000000065 · DOI · Paper page
- Lonn, 2016, Blood pressure lowering in intermediate risk persons without cardiovascular disease, N Engl J Med, 374, 2009, 10.1056/NEJMoa1600175 · DOI · Paper page
- Parati, 2017, SPRINT blood pressure; sprinting back to Smirk's basal blood pressure?, Hypertension, 69, 15, 10.1161/HYPERTENSIONAHA.116.08216 · DOI
- Thomopoulos, 2016, Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events – meta-analyses of randomized trials, J Hypertens, 34, 1451, 10.1097/HJH.0000000000000972 · DOI · Paper page
- Fagard, 2011, Exercise therapy in hypertensive cardiovascular disease, Prog Cardiovasc Dis, 53, 404, 10.1016/j.pcad.2011.03.006 · DOI
- Leong, 2015, Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) Study, Lancet, 836, 266, 10.1016/S0140-6736(14)62000-6 · DOI · Paper page
- Thomopoulos, 2015, Effects of blood pressure lowering on outcome incidence in hypertension 5. Head-to-head comparisons of various classes of antihypertensive drugs. Overview and meta-analyses, J Hypertens, 33, 1321, 10.1097/HJH.0000000000000614 · DOI · Paper page
- Thomopoulos, 2014, Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk-overview and meta-analyses of randomized trials, J Hypertens, 32, 2305, 10.1097/HJH.0000000000000380 · DOI · Paper page
- Gupta, 2010, Compliance, safety and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis, Hypertension, 55, 399, 10.1161/HYPERTENSIONAHA.109.139816 · DOI · Paper page
- Patel, 2016, Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the Standardized Hypertension Treatment and Prevention Project, J Clin Hypertens, 18, 1284, 10.1111/jch.12861 · DOI · Paper page
- Khatib, 2016, Availability and affordability of cardiovascular disease medicines and their effect on use in high income, middle income and low income countries: an Analysis of the PURE Study Data, Lancet, 387, 61, 10.1016/S0140-6736(15)00469-9 · DOI · Paper page
- 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group., BMJ, 317, 703, 10.1136/bmj.317.7160.703 · DOI · Paper page
- Cederholm, 2012, Blood pressure and risk of cardiovascular disease in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP-II), J Hypertens, 30, 2020, 10.1097/HJH.0b013e3283577bdf · DOI
- Bigazzi, 1998, Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension, J Hypertens, 16, 1325, 10.1097/00004872-199816090-00014 · DOI · Paper page
- Jensen, 2000, Arterial hypertension, microalbuminuria and risk of ischemic heart disease, Hypertension, 35, 898, 10.1161/01.HYP.35.4.898 · DOI · Paper page
- Arnlov, 2005, Lowgrade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study, Circulation, 112, 969, 10.1161/CIRCULATIONAHA.105.538132 · DOI · Paper page
- Bonadonna, 2016, Novel antidiabetic drugs and cardiovascular risk: primum non nocere, Nutr Metab Cardiovasc Dis, 26, 759, 10.1016/j.numecd.2016.05.007 · DOI
- Son, 2015, Dipeptidyl Peptidase 4 inhibitors and the risk of cardiovascular disease in patients with type 2 diabetes: a tale of three studies, Diabetes Metab J, 39, 373, 10.4093/dmj.2015.39.5.373 · DOI
- Abdul-Ghani, 2016, SGLT-2 inhibitors and cardiovascular risk: lessons learned from the EMPA-REG outcome Study, Diabetes Care, 39, 715, 10.2337/dc16-0041 · DOI · Paper page
- Pfeifer, 2017, Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis, Cardiovasc Diabetol, 16, 29, 10.1186/s12933-017-0511-0 · DOI · Paper page
- Peek, 1996, Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome?, Obstet Gynecol, 88, 1030, 10.1016/S0029-7844(96)00350-X · DOI
- Ferrazzani, 1990, Proteinuria and outcome of 444 pregnancies complicated by hypertension, Am J Obstet Gynecol, 162, 366, 10.1016/0002-9378(90)90387-M · DOI · Paper page
- Wilson, 2002, Molecular epidemiology of preeclampsia, Obstet Gynecol Surv, 58, 39, 10.1097/00006254-200301000-00022 · DOI · Paper page
- Redmond, 2011, Health behaviors and racial disparity in blood pressure control in the national health and nutrition examination survey, Hypertension, 57, 383, 10.1161/HYPERTENSIONAHA.110.161950 · DOI · Paper page
- Fuchs, 2011, Why do black Americans have higher prevalence of hypertension? An enigma still unsolved, Hypertension, 57, 379, 10.1161/HYPERTENSIONAHA.110.163196 · DOI
Cited by
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Omboni, S., McManus, R. J., Bosworth, H. B., Chappell, L. C., Green, B. B., Kario, K., Logan, A. G., Magid, D. J., Mckinstry, B., Margolis, K. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15873 · Cited by 307
Sánchez, R. A., Boggia, J., Peñaherrera, E., Barroso, W. S., Barbosa, E., Villar, R., Cobos, L., Hernández Hernández, R., Lopez, J., Octavio, J. A., et al. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13816 · Cited by 38
Villar, R., Sánchez, R. A., Boggia, J., Peñaherrera, E., Lopez, J., Barroso, W. S., Barbosa, E., Cobos, L., Hernández Hernández, R., Octavio, J. A., et al. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13815 · Cited by 28
Metadata
- Venue
- Journal of Hypertension
- Published
- 2017-08
- Volume
- 35
- Issue
- 8
- Pages
- 1529-1545
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2782397703
- Cited by
- 73
- References
- 26
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines on the management of arterial hypertension and related comorbidities in Latin America. https://app.cochat.ai/papers/10.1097/hjh.0000000000001418
- The paper
- Guidelines on the management of arterial hypertension and related comorbidities in Latin America. (2017). Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000001418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.